Nivolumab treatment followed by atezolizumab induced encephalitis and neuropathy with antiganglioside antibodies

eNeurologicalSci. 2021 Dec 3:25:100386. doi: 10.1016/j.ensci.2021.100386. eCollection 2021 Dec.

¹ Department of Neurology, Hyogo College of Medicine, Nishinomiya 663-8501, Japan.
² Department of Respiratory Medicine and Hematology, Hyogo College of Medicine, Nishinomiya 663-8501, Japan.

No abstract available

Keywords: Antiganglioside antibodies; Atezolizumab; Encephalitis; Immune-related adverse events; Neuropathy; Nivolumab.